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A 57-year-old woman stumbled over her carpet, almost fell, 
and tried to sit down on the floor, when she heard a crack and 
sustained a transverse diaphyseal fracture of her left femur. 
The fracture had been preceded by thigh pain for a couple of 
months, but this was thought to be caused by spinal stenosis, 
for which she had been operated twice. She had been diag-
nosed with seronegative rheumatoid arthritis 10 years before 
the  fracture  and  had  initially  undergone  different  pharma-
cologcal treatments, all of which except cortisone had been 
terminated. The diagnosis was repeatedly doubted, but cor-
tisone gave symptomatic relief and was therefore continued 
at 5 mg/day with intermittent high-dose treatment (25 mg/
day) during exacerbations. Apart from prednisolone, no anti-
rheumatic drugs had been given during the previous 6 years. 
The patient had been given alendronate (70 mg/week) in 2001, 
followed by risedronate (35 mg/week) from 2002 until the 
fracture in 2009. The patient had also been taking 20–40 mg 
omeprazol a day since 2000. 
The fracture had a typical fatigue fracture appearance (Nev-
iaser et al. 2008), and was operated on with intramedullary 
nailing. Because of a history of pain on weight bearing also 
in her contralateral thigh, new radiographs were taken and 
showed a non-displaced stress fracture of the subtrochanteric 
region (Figure 1). This fracture was also treated with intra-
medullary nailing.
Surgery (second operation)
After the nail had been inserted, the non-displaced fracture 
was exposed. It could be seen as a dark line the size of a hair 
on the bone surface, surrounded by a barely visible protrusion 
of the bone. A 12 × 15-mm specimen including the fracture 
was excised, with the patient’s informed consent. The proce-
dure was approved by the Regional Ethics Committee. Both 
fractures healed uneventfully and mineralized callus was seen 
at the biopsy site after 5 months. 
Histology
The specimen was divided in halves. The frontal half was 
prepared for visualization of microcracks (Burr and Hooser 
1995) but this failed for technical reasons. The dorsal half of 
the specimen was demineralized, embedded in paraffin, sec-
tioned in the sagittal plane, parallel to the periosteal surface, 
and stained either with HE or with an anti-TRAP antibody 
(a gift from G Andersson, Karolinska Institute, Stockholm) to 
identify osteoclasts.
Figure 1. Right femur. Arrow indicates undisplaced fatigue fracture. Acta Orthopaedica 2010; 81 (4): 460–462  461
Sections parallel to the cortical surface were analyzed at 
every 0.5 mm from the periosteum to the endosteal callus. 
The intact bone at 7 mm distance from the fracture showed 
a regular osteonal structure with osteocyte lacunae, but very 
few of these lacunae contained osteocytes. The bone matrix 
showed paler staining than the bone rich in live osteocytes, 
seen at other sites (see below). Some osteocyte lacunae in 
the  osteocyte-less  bone  were  indistinctly  delineated. There 
were numerous irregular small cracks in the matrix. These 
cracks were only seen in osteocyte-less matrix, and not in the 
younger osteocyte-rich bone. Occasionally, a wide vascular 
canal with some bone formation was seen within the regions 
without osteocytes.
The fracture appeared mostly as a meandering empty crack, 
only 0.1 mm wide or less. In some areas, it appeared as a band 
of necrotic material (Figure 2), consisting of diffusely dam-
aged and disintegrated bone, with a sharp border to the sur-
rounding bone. Fibrous or cartilaginous tissue was never seen 
within the crack or adjacent to it, and no vessels were seen to 
approach it. In contrast to the bone at a greater distance from 
the crack, the bone in its vicinity, inside the femoral cortex, 
contained numerous resorption cavities with loose marrow. 
Many of these contained large osteoclasts (Figure 2), some-
times with extremely large numbers of nuclei and with detach-
ment from the underlying bone surface in accordance with find-
ings described by Weinstein et al. (2009). Here the bone was 
rich in osteocytes, which were often rounded in shape. There 
were few empty lacunae. The bone had lost its regular osteo-
nal architecture, and remodeling appeared to have occurred in 
all planes and directions. Remnants of mature osteonal bone 
were seen interspersed with this irregular young bone. In the 
old bone, almost all osteocyte lacunae were empty. 
There were only minor differences between sections at dif-
ferent depths from the outer surface within the cortex. How-
ever, adjacent to the bone marrow there was an endosteal callus 
with very little necrotic bone, but instead a dense remodeled 
bone with an irregular osteonal structure and vivid ongoing 
remodeling. The fracture crack terminated within this new 
bone. Near the periosteal surface there were no differences 
from the interior of the cortex, except superficially, where a 
thin layer of immature bone (callus) was seen. 
Osteocytes were counted in 3 sections, 0.5 mm apart, cor-
responding to approximate depths of 1.5, 2, and 2.5 mm from 
the periosteal bone surface. The measured area in each section 
was a 1 × 5-mm rectangle, oriented parallel to the fracture, 
about 7 mm away from it. Of 1,967 lacunae counted, only 
488 of them (25 %%) contained visible cellular material. As 
a control, new-formed bone in the endosteal callus was ana-
lyzed in a similar way, which showed that 86% of the lacunae 
contained cellular material, despite the fact that some necrotic 
bone was included in the area analyzed.
Not a single multinucleated TRAP-positive cell was identi-
fied in the measuring area 7 mm away from the crack, whereas 
there were 7 such cells per mm2 of specimen surface in the 
fracture region (385 cells counted).
Discussion
Stress fractures in association with bisphosphonate treatment 
have attracted attention recently (Aspenberg 2009). It appears 
that in this case the fracture had occurred in bone that was 
almost completely devoid of osteocytes. However, the cortical 
bone was able to undergo osteoclastic resorption adjacent to 
the fracture, showing that remodeling was possible. Targeted 
remodeling is thought to be initiated by signals from dying 
osteocytes, and it thus requires these cells to be present. Either 
the remaining small numbers of osteocytes were sufficient or 
some other mechanism may have initiated resorption.
The abundant, diffusely damaged and disintegrated bone 
in the fracture region is puzzling (Figure 2). It does not fit 
with the common description of diffuse microdamage (Burr, 
personal communication). Although it might have caused the 
fracture, its location—almost exclusively at the crack—sug-
gests that it could have been secondary to the fracture. 
Somford et al. (2009) recently described markedly increased 
resorption within a cortical biopsy taken about 1 cm from the 
fracture in a similar case. Their findings suggest that the bone 
was  weakened  due  to  resorption.  In  our  patient,  however, 
resorption was limited to the immediate vicinity of the frac-
ture and was obviously a consequence of it, and the fracture 
ran through areas of necrotic bone.
 Long-term bisphosphonate treatment dramatically increases 
the risk of femoral stress fracture, although the annual risk 
is still only about 1 in 1,000 (95% CI: 0.2–2) (Schilcher and 
Aspenberg 2009). It appears that both cortisone and proton 
Figure 2. Histology of the fracture, seen both as a vertical crack through 
the image (white arrows) and as areas of diffusely damaged and disin-
tegrated bone (black horizontal arrows). A resorption cavity with giant 
detached  osteoclasts  (black  vertical  arrows)  and  new-formed  bone 
with rounded osteocytes can be seen near the fracture.462  Acta Orthopaedica 2010; 81 (4): 460–462
pump inhibitors can increase the risk (Kwek et al. 2008, Ing-
Lorenzini et al. 2009), and our patient was taking both of 
these drugs as well. The lack of living osteocytes in the cen-
tral femoral cortex suggests that the bone had become too old 
for osteocyte survival, due to severe suppression of remodel-
ing, or that corticosteroids had induced osteocyte apoptosis, 
or probably both. Stress fractures are thought to be initiated 
by microcrack accumulation in bone that has not undergone 
timely remodeling, or which has become highly mineralized 
and brittle for the same reason. 
Stress fractures heal slowly. Still, in our case, the cortical bone 
near the crack was able to undergo intense remodeling in spite of 
its bisphosphonate content. Even though some osteoclasts may 
have shown pathological histological features such as detach-
ment and giant size, their number and activity was sufficient 
for extensive remodeling. This suggests that non-healing of the 
fracture and its possible progression to gross failure was related 
to the mechanics or geometry of the crack, and not to qualities 
of the surrounding bone or the patient’s ability to heal. It was 
striking that the crack did not contain any new-formed tissue. 
A speculative explanation would be that because the crack was 
so narrow, even a small physiological strain that would widen 
or compress the crack by fractions of a millimeter would cause 
a local strain sufficient to tear apart any cell or vessel daring to 
enter the area. Thus, although our patient’s fracture may have 
been initiated in “frozen bone” due to bisphosphonate treatment, 
its inability to heal may have had similar causes to those for 
stress fractures in general.
Although this patient showed a striking lack of osteocytes, 
our findings do not explain the detailed mechanisms behind 
initiation of the fracture. In order to do that, one would have 
to study biopsies from this region, before the fracture has 
occurred, with specific methods to visualize microcracks and 
diffuse microdamage.
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